30718944|t|Melatonin receptor stimulation by agomelatine prevents Abeta-induced tau phosphorylation and oxidative damage in PC12 cells.
30718944|a|PURPOSE: As a novel antidepressant drug, agomelatine has good therapeutic effect on the mood disorder and insomnia in Alzheimer's disease (AD). Recent studies have shown the neuroprotective function of agomelatine, including anti-oxidative and anti-apoptosis effect. However, it remains unclear whether agomelatine exerts neuroprotection in AD. Thus, the neuroprotective effect of agomelatine against amyloid beta 25-35 (Abeta25-35)-induced toxicity in PC12 cells was evaluated in this study. METHODS: The concentration of malondialdehyde (MDA), LDH, and ROS was investigated to evaluate oxidative damage. The expression of P-tau, tau, PTEN, P-Akt, Akt, P-GSK3beta, and GSK3beta proteins was assessed by Western blotting. Our results demonstrated that Abeta25-35 significantly increased the content of MDA, LDH, and ROS. Meanwhile, Abeta25-35 upregulated the expression of P-tau and PTEN as well as downregulated P-Akt and P-GSK3beta expression. These effects could be blocked by agomelatine pretreatment. Furthermore, luzindole, the melatonin receptor (MT) antagonist, could reverse the neuroprotective effect of agomelatine. CONCLUSION: The results demonstrated that antidepressant agomelatine might prevent the tau protein phosphorylation and oxidative damage induced by Abeta25-35 in PC12 cells by activating MT-PTEN/Akt/GSK3beta signaling. This study provided a novel therapeutic target for AD in the future.
30718944	34	45	agomelatine	Chemical	MESH:C084711
30718944	55	60	Abeta	Gene	54226
30718944	113	117	PC12	CellLine	CVCL:0481
30718944	166	177	agomelatine	Chemical	MESH:C084711
30718944	213	226	mood disorder	Disease	MESH:D019964
30718944	231	239	insomnia	Disease	MESH:D007319
30718944	243	262	Alzheimer's disease	Disease	MESH:D000544
30718944	264	266	AD	Disease	MESH:D000544
30718944	327	338	agomelatine	Chemical	MESH:C084711
30718944	428	439	agomelatine	Chemical	MESH:C084711
30718944	466	468	AD	Disease	MESH:D000544
30718944	506	517	agomelatine	Chemical	MESH:C084711
30718944	566	574	toxicity	Disease	MESH:D064420
30718944	578	582	PC12	CellLine	CVCL:0481
30718944	648	663	malondialdehyde	Chemical	MESH:D008315
30718944	665	668	MDA	Chemical	MESH:D008315
30718944	680	683	ROS	Chemical	-
30718944	761	765	PTEN	Gene	50557
30718944	769	772	Akt	Gene	24185
30718944	774	777	Akt	Gene	24185
30718944	781	789	GSK3beta	Gene	84027
30718944	795	803	GSK3beta	Gene	84027
30718944	927	930	MDA	Chemical	MESH:D008315
30718944	941	944	ROS	Chemical	-
30718944	1008	1012	PTEN	Gene	50557
30718944	1040	1043	Akt	Gene	24185
30718944	1050	1058	GSK3beta	Gene	84027
30718944	1105	1116	agomelatine	Chemical	MESH:C084711
30718944	1144	1153	luzindole	Chemical	MESH:C057154
30718944	1239	1250	agomelatine	Chemical	MESH:C084711
30718944	1309	1320	agomelatine	Chemical	MESH:C084711
30718944	1413	1417	PC12	CellLine	CVCL:0481
30718944	1441	1445	PTEN	Gene	50557
30718944	1446	1449	Akt	Gene	24185
30718944	1450	1458	GSK3beta	Gene	84027
30718944	1521	1523	AD	Disease	MESH:D000544
30718944	Negative_Correlation	MESH:C084711	MESH:D000544
30718944	Association	MESH:C084711	50557
30718944	Association	MESH:C084711	24185
30718944	Negative_Correlation	MESH:C084711	MESH:D007319
30718944	Association	MESH:C084711	84027
30718944	Negative_Correlation	MESH:C084711	MESH:D019964
30718944	Negative_Correlation	MESH:C084711	54226
30718944	Association	MESH:C084711	MESH:D064420
30718944	Association	MESH:C057154	MESH:C084711

